Sherwin-Williams (SHW) director receives new restricted stock award

Rhea-AI Filing Summary

Sherwin-Williams director Jeff M. Fettig reported an equity award from the company. On February 17, 2026, he acquired 558 shares of Common Stock at $0 as part of a grant of restricted stock units under the 2025 Equity and Incentive Compensation Plan. The RSUs vest in three substantially equal annual installments starting February 16, 2027. After this award, he beneficially owns 7,019 shares, consisting of 1,100 RSUs and 5,919 shares of Common Stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FETTIG JEFF M

(Last) (First) (Middle)

1 SHERWIN WAY

(Street)

CLEVELAND OH 44113

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SHERWIN WILLIAMS CO [ SHW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/17/2026		A		558(1)	A	$0	7,019(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units ("RSUs"), pursuant to the terms of an RSU agreement under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock. The RSUs vest annually in three substantially equal installments commencing February 16, 2027.

2. These securities consist of 1,100 RSUs and 5,919 shares of Common Stock.

Remarks:

	Stephen J. Perisutti, Attorney-in-fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did SHW director Jeff M. Fettig report?

Jeff M. Fettig reported receiving an equity award from Sherwin-Williams. On February 17, 2026, he acquired 558 shares of Common Stock at $0 as part of a restricted stock unit grant under the 2025 Equity and Incentive Compensation Plan.

How many Sherwin-Williams (SHW) shares does Jeff M. Fettig now beneficially own?

After the reported transaction, Jeff M. Fettig beneficially owns 7,019 Sherwin-Williams shares. This total includes 1,100 restricted stock units and 5,919 shares of Common Stock, as disclosed in the filing’s footnotes and post-transaction ownership column.

What are the vesting terms of Jeff M. Fettig’s new Sherwin-Williams RSUs?

The restricted stock units granted to Jeff M. Fettig vest over three years. They vest annually in three substantially equal installments, beginning on February 16, 2027, according to the terms of the 2025 Equity and Incentive Compensation Plan.

Was the Sherwin-Williams (SHW) insider transaction an open-market purchase or a grant?

The transaction was a grant, not an open-market purchase. Fettig acquired 558 shares of Common Stock at a price of $0, characterized as a grant or award of restricted stock units under the company’s 2025 equity and incentive compensation plan.

Under which plan were Jeff M. Fettig’s Sherwin-Williams RSUs granted?

Jeff M. Fettig’s restricted stock units were granted under The Sherwin-Williams Company 2025 Equity and Incentive Compensation Plan. Each RSU represents the right to receive one share of Common Stock, subject to the plan’s vesting schedule and other standard terms.